Harrow (HROW) Income towards Parent Company (2010 - 2026)

Harrow's (HROW) quarterly Income towards Parent Company came in at -$27.6 million in Q1 2026, down 55.24% year-on-year from -$61.7 million in Q1 2025, and down 365.48% quarter-over-quarter from $10.4 million in Q4 2025.

Harrow (HROW) Income towards Parent Company (2010 - 2026) Analysis & Trends

Harrow's Income towards Parent Company history runs 17 years deep, the most recent figure standing at -$27.6 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 55.24% year-over-year to -$27.6 million in Q1 2026; TTM through Mar 2026 was -$11.2 million, a 48.42% increase from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 70.6% from the prior year.
  • Income towards Parent Company fell to -$27.6 million in Q1 2026 per HROW's latest filing, from $10.4 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $10.4 million in Q4 2025 and bottomed at -$27.6 million in Q1 2026.
  • The 5-year median for Income towards Parent Company is -$4.4 million (2023), against an average of -$5.0 million.
  • Across the five-year window, Income towards Parent Company plunged 1223.5% in 2022 and surged 177.17% in 2025, its largest moves.
  • Year by year, Income towards Parent Company stood at $1.1 million in 2022, then plunged by 967.11% to -$9.1 million in 2023, then surged by 174.08% to $6.8 million in 2024, then surged by 53.42% to $10.4 million in 2025, then plunged by 365.48% to -$27.6 million in 2026.
  • Per Business Quant, the three latest HROW Income towards Parent Company figures stand at -$27.6 million (Q1 2026), $10.4 million (Q4 2025), and $1.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.91 Bn 88.04 Bn -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Harrow 1.42 Bn 1.32 Bn 27.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -27.60 Mn
Dec 31, 2025 10.40 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -13.57 Mn
Dec 31, 2023 -9.15 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -6.64 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 -6.24 Mn
Mar 31, 2022 -2.44 Mn
Dec 31, 2021 -7.29 Mn
Sep 30, 2021 -8.33 Mn
Jun 30, 2021 -2.48 Mn